healthcare News
HCW Biologics Stock Soars on Cancer Immunotherapy Breakthrough
Shares surge over 85% after the company reveals a next-generation cancer drug that outperformed leading treatments in preclinical studies.
AxoGen Nerve Graft Decision Pushed Back by FDA
Regulator extends review for Avance Nerve Graft to December after new manufacturing data requires more time for evaluation.
Moderna Gains Canadian Approval For Updated COVID Vaccine
Health Canada authorizes Spikevax targeting LP.8.1 variant, with all pre-filled syringe doses for 2025 to be produced domestically.
Tharimmune Stock Surges Over 200% on Opioid Countermeasure Data
Positive FDA feedback and promising 24-hour protection data for its fentanyl overdose prophylactic, TH104, fuel the rally.
Iovance Soars as Melanoma Drug Gains First International Approval
Health Canada's conditional nod for Amtagvi opens new markets for the cell therapy, following its earlier US FDA approval.
Viking Therapeutics Plummets 43% Despite Positive Obesity Drug Data
Impressive Phase 2 trial results for its oral weight-loss pill were not enough to satisfy high investor expectations, triggering a massive sell-off.